ChIP-seq Analysis to Explore DNA Replication Profile in Trifluridine-treated Human Colorectal Cancer Cells


Journal

Anticancer research
ISSN: 1791-7530
Titre abrégé: Anticancer Res
Pays: Greece
ID NLM: 8102988

Informations de publication

Date de publication:
Jul 2019
Historique:
received: 18 02 2019
revised: 23 03 2019
accepted: 26 03 2019
entrez: 3 7 2019
pubmed: 3 7 2019
medline: 10 7 2019
Statut: ppublish

Résumé

Trifluridine (FTD) is a key component of the novel oral antitumor drug trifluridine/tipiracil that has been approved for the treatment of metastatic colorectal cancer. In this study, a comprehensive analysis of DNA replication profile in FTD-treated colon cancer cells was performed. HCT-116 cells were exposed to BrdU or FTD and subjected to DNA immunoprecipitation. Immunoprecipitated DNA was sequenced; the density of aligned reads along the genome was calculated. Peak finding, gene ontology, and motif analysis were performed using MACS, GREAT, and MEME, respectively. We identified 6,043 and 5,080 high-confidence FTD and BrdU peaks in HCT-116 cells, respectively. Of 6,043 FTD peaks, 2,911 peaks were uncommon to BrdU. We observed that FTD was preferentially incorporated into genomic regions containing simple repeats, CpG islands, and gene bodies. Conserved motifs in FTD peaks contained dinucleotide repeats such as (GT)n. Global FTD incorporation patterns delineated FTD, preferentially incorporating loci in cancer cells.

Sections du résumé

BACKGROUND/AIM OBJECTIVE
Trifluridine (FTD) is a key component of the novel oral antitumor drug trifluridine/tipiracil that has been approved for the treatment of metastatic colorectal cancer. In this study, a comprehensive analysis of DNA replication profile in FTD-treated colon cancer cells was performed.
MATERIALS AND METHODS METHODS
HCT-116 cells were exposed to BrdU or FTD and subjected to DNA immunoprecipitation. Immunoprecipitated DNA was sequenced; the density of aligned reads along the genome was calculated. Peak finding, gene ontology, and motif analysis were performed using MACS, GREAT, and MEME, respectively.
RESULTS RESULTS
We identified 6,043 and 5,080 high-confidence FTD and BrdU peaks in HCT-116 cells, respectively. Of 6,043 FTD peaks, 2,911 peaks were uncommon to BrdU. We observed that FTD was preferentially incorporated into genomic regions containing simple repeats, CpG islands, and gene bodies. Conserved motifs in FTD peaks contained dinucleotide repeats such as (GT)n.
CONCLUSION CONCLUSIONS
Global FTD incorporation patterns delineated FTD, preferentially incorporating loci in cancer cells.

Identifiants

pubmed: 31262880
pii: 39/7/3565
doi: 10.21873/anticanres.13502
doi:

Substances chimiques

Antimetabolites, Antineoplastic 0
Bromodeoxyuridine G34N38R2N1
Trifluridine RMW9V5RW38

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3565-3570

Informations de copyright

Copyright© 2019, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Auteurs

Takashi Kobunai (T)

Taiho Pharmaceutical Co., Ltd., Translational Research Laboratory, Tokyo, Japan takashi_kobunai@taiho.co.jp.

Kazuaki Matsuoka (K)

Taiho Pharmaceutical Co., Ltd., Translational Research Laboratory (Tokushima office), Tokushima, Japan.

Teiji Takechi (T)

Taiho Pharmaceutical Co., Ltd., Translational Research Laboratory, Tokyo, Japan.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH